Christopher W. Fulton

Array ( [id] => 7297945 [patent_doc_number] => 20040214989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Compatible-multiphase organic solvent system' [patent_app_type] => new [patent_app_number] => 10/486383 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9659 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214989.pdf [firstpage_image] =>[orig_patent_app_number] => 10486383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 473068 [patent_doc_number] => 07230074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Inhibitors of dipeptidyl-aminopeptidase type IV' [patent_app_type] => utility [patent_app_number] => 10/775598 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5919 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/230/07230074.pdf [firstpage_image] =>[orig_patent_app_number] => 10775598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632369 [patent_doc_number] => 20060148839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'New pharmaceutical compositions based on anticholinergics and tace-inhibitors' [patent_app_type] => utility [patent_app_number] => 10/544238 [patent_app_country] => US [patent_app_date] => 2004-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9684 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148839.pdf [firstpage_image] =>[orig_patent_app_number] => 10544238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 377093 [patent_doc_number] => 07312193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Calcium phosphopeptide complexes' [patent_app_type] => utility [patent_app_number] => 10/769980 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8967 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312193.pdf [firstpage_image] =>[orig_patent_app_number] => 10769980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7006028 [patent_doc_number] => 20050171341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Methods for stabilizing proteins' [patent_app_type] => utility [patent_app_number] => 10/771595 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2148 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171341.pdf [firstpage_image] =>[orig_patent_app_number] => 10771595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180481 [patent_doc_number] => 20050124548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Peptide antiangiogenic drugs' [patent_app_type] => utility [patent_app_number] => 10/764379 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70608 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124548.pdf [firstpage_image] =>[orig_patent_app_number] => 10764379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5672941 [patent_doc_number] => 20060178296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Night-time oral insulin therapy' [patent_app_type] => utility [patent_app_number] => 10/541433 [patent_app_country] => US [patent_app_date] => 2004-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17643 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178296.pdf [firstpage_image] =>[orig_patent_app_number] => 10541433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405293 [patent_doc_number] => 20040175738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Novel osteopontin derived chemotactic peptides and methods of use' [patent_app_type] => new [patent_app_number] => 10/743892 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12782 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175738.pdf [firstpage_image] =>[orig_patent_app_number] => 10743892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637918 [patent_doc_number] => 07125872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins' [patent_app_type] => utility [patent_app_number] => 10/745471 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 25448 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125872.pdf [firstpage_image] =>[orig_patent_app_number] => 10745471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618763 [patent_doc_number] => 07998477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Spherical protein particles and methods for making and using them' [patent_app_type] => utility [patent_app_number] => 10/741861 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30817 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998477.pdf [firstpage_image] =>[orig_patent_app_number] => 10741861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102621 [patent_doc_number] => 07728105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Peptides impairing PBX dependent gene regulation' [patent_app_type] => utility [patent_app_number] => 10/538723 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18256 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728105.pdf [firstpage_image] =>[orig_patent_app_number] => 10538723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467654 [patent_doc_number] => 20040120897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method for administering insulinotropic peptides' [patent_app_type] => new [patent_app_number] => 10/732091 [patent_app_country] => US [patent_app_date] => 2003-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8517 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120897.pdf [firstpage_image] =>[orig_patent_app_number] => 10732091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707867 [patent_doc_number] => 07060683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Hydroxamate-containing cysteine and serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/717773 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7185 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060683.pdf [firstpage_image] =>[orig_patent_app_number] => 10717773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674641 [patent_doc_number] => 20040127477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Heterocyclic glycyl beta-alanine derivatives' [patent_app_type] => new [patent_app_number] => 10/718328 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38678 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127477.pdf [firstpage_image] =>[orig_patent_app_number] => 10718328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411053 [patent_doc_number] => 20040106560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Neuroprotective agents' [patent_app_type] => new [patent_app_number] => 10/719599 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11508 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106560.pdf [firstpage_image] =>[orig_patent_app_number] => 10719599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968672 [patent_doc_number] => 06939947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'N1-modified glycopeptides' [patent_app_type] => utility [patent_app_number] => 10/717163 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4989 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939947.pdf [firstpage_image] =>[orig_patent_app_number] => 10717163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151558 [patent_doc_number] => 07683025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Synthesis and self-assembly of ABC triblock bola peptide amphiphiles' [patent_app_type] => utility [patent_app_number] => 10/534266 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 3533 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/683/07683025.pdf [firstpage_image] =>[orig_patent_app_number] => 10534266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338049 [patent_doc_number] => 20040132958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods and compositions for controlled polypeptide synthesis' [patent_app_type] => new [patent_app_number] => 10/712967 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36806 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132958.pdf [firstpage_image] =>[orig_patent_app_number] => 10712967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367181 [patent_doc_number] => 20040092436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins' [patent_app_type] => new [patent_app_number] => 10/702427 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9214 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092436.pdf [firstpage_image] =>[orig_patent_app_number] => 10702427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656815 [patent_doc_number] => 20060142551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods for removing suspended particles from soluble protein solutions' [patent_app_type] => utility [patent_app_number] => 10/698238 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5854 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142551.pdf [firstpage_image] =>[orig_patent_app_number] => 10698238 [rel_patent_id] =>[rel_patent_doc_number] =>)